Pharmadrug Inc. operates as a specialty pharmaceutical company. The company focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. It also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and research and development activities in the psychedelics space for the treatment of non-neuropsychiatric conditions. It has a license agreement with Southwest Research Institute. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. Pharmadrug Inc. was incorporated in 2011 and is based in Toronto, Canada.
Frequently asked questions
What sector does Pharmadrug Inc. (PHRX) operate in?
Pharmadrug Inc. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Pharmadrug Inc. (PHRX) current stock price?
As of the latest data, Pharmadrug Inc. stock price is CA$0.01, with a previous close of CA$0.01.
What is Pharmadrug Inc. (PHRX) current market capitalization?
Pharmadrug Inc. market cap is approximately 1.34 million.
Does Pharmadrug Inc. (PHRX) pay dividends?
No. Pharmadrug Inc. does not pay a dividend.
What is Pharmadrug Inc. (PHRX) beta (volatility) score?
Pharmadrug Inc. has a beta of 0.890, meaning its volatility is roughly in line with the market.
